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Abstract
We used electron microscopy, quasi-elastic light scattering and static light scattering to show that human hemoglobin
 .Hb interacts with bovine brain phosphatidylserine lipid vesicles and promotes vesicle fusion in an isotonic buffer at pH
 .7.4. The fusogenic properties of Hb were observed in both small unilamellar vesicles SUVs and large unilamellar vesicles
 .  .LUVs . A simple turbidity measurement method was used to follow increases in vesicle size scattering diameter as a
function of time. For the first 3 h, upon incubation with oxygenated Hb, the scattering diameters of vesicles increased at a
rate of 7.8 nmrh for LUVs. Continuous incubation with Hb led to complicated vesicle fusion, probably due to the oxidation
products of Hb and lipid molecules. In the absence of both Hb and lipid oxidation, using Hb liganded with carbon
monoxide, we obtained, for the entire 20 h incubation period, a fusion rate of 2.9 nmrh for LUVs. We also studied
interactions between sickle Hb and vesicles under the same conditions and found that the vesicle fusion rates for sickle Hb
were about 2 times faster than those for normal Hb. These results showed that sickle Hb exhibited more extensive
interactions with lipid bilayer than normal Hb at physiological pH and ionic strength conditions, and provide insights toward
understanding the molecular mechanisms in sickle cell abnormalities. q 1998 Elsevier Science B.V.
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1. Introduction
Hemoglobin aggregation on erythrocyte mem-
branes has been observed in cells with abnormal Hb
w xmolecules 1–4 , often leading to Heinz body forma-
tion. It has been reported that oxidized Hb promotes
aggregation on the membrane surface at low pH and
w xionic strength 5 . However, the molecular mecha-
nism of the Hb aggregation on membrane surfaces
under physiological conditions is not clear. Hb-mem-
brane interactions have been extensively studied,
w xmostly at low pH and low ionic strength 5–11 .
Band 3 has been postulated to participate in the Hb
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binding to erythrocyte membranes at pH 6 in buffers
w xwith low ionic strength 12 . However, no binding
was observed at pH 7.4 in buffers with 150 mM NaCl
w x7 . Interactions between Hb and membrane at
physiological pH and ionic strength conditions were
presumably much weaker than those at low pH and
low ionic strength conditions, and thus more difficult
to assess experimentally. Furthermore, Hb and lipid
molecules are both prone to oxidation in Hb–lipid
w xmixtures 13,14 making interaction studies difficult.
Only few studies have been carried out at physio-
w xlogical pH and ionic strength 9,10,14 .
We have shown that the lipid surface, in the
absence of lipid peroxidation, interacts with normal
HbA and promotes Hb oxidation in buffers with
w xphysiological pH and ionic strength 14 . In this
study, we used electron microscopy, quasi-elastic
light scattering and static light scattering to show that
Hb, in the absence of Hb oxidation, promotes BPS
lipid vesicle fusion at pH 7.4 in buffers with physio-
logical ionic strength. We also monitored the sizes of
vesicles as a function of time in Hb-vesicle mixtures
under different experimental conditions and deter-
mined rates of Hb-mediated vesicle fusion.
Phospholipid vesicle fusion has been studied ex-
w xtensively 15–17 . In particular, mechanisms of pro-
w xtein mediated vesicle fusion are emerging 16,18–21 .
Thus, the studies of Hb-mediated vesicle fusion pro-
vide us the means to understand properties of Hb
near lipid surface. We also studied the effects of
HbS, an Hb variant exhibiting higher surface hy-
drophobicity than HbA, on vesicle fusion. We found
that HbS was more fusogenic, and thus destabilized
the lipid surface to a larger extent than HbA. Results
from these studies not only provided direct evidence
to demonstrate that Hb interacted with lipid surface at
physiological pH and ionic strength, but also pro-
vided further information about the molecular mecha-
nisms in sickle cell abnormalities.
2. Materials and methods
HPLC-grade water was used for all buffers fol-
 .lowed by treatment with Chelex Bio-Rad . All glass-
ware was acid-washed to remove potential contami-
nants.
2.1. Hemoglobin
Fresh normal red blood cells were obtained from a
local blood bank. Sickle red blood cells were ob-
tained from Mt. Sinai Hospital, Chicago, IL. Hb was
prepared from red blood cells at 48C by column
chromatography with a pH gradient to give ‘ultra-
w xpure’ Hb, as described previously 14 . Sickle and
normal red cells were processed in tandem to ensure
identical buffer conditions. Since we were comparing
molecular properties of HbA and HbS, parallel pro-
cessing of HbA and HbS was critical to eliminate a
number of confounding variables introduced when
samples had different histories. The HbA fractions
eluted at pH 7.75, and the HbS eluted at pH 7.90.
This procedure removed all minor hemoglobin com-
ponents, catalase, superoxide dismutase, ‘adventi-
w xtious’ metals, and other red cell proteins 22,23 . The
identities and purity of HbA and HbS were also
w xconfirmed with cellulose acetate electrophoresis 24 .
The HbA or HbS fractions were pooled, concentrated
by ultrafiltration cells, dialyzed against 35 mM
sodium phosphate buffer with 2 mM EDTA and 110
 .mM NaCl at pH 7.4 PEN7.4 , and CO gassed to
give COHb. Before use, the COHb was converted to
oxyHb on ice under a flood light and O atmosphere.2
Full removal of CO from the oxyHb was obtained
when absorption values of the sample at 540 and 569
nm were the same. Samples with detectable oxidized
 .Hb, as indicated by detectable absorbance )0.01 at
630 nm, were discarded. The concentration of Hb
 .was adjusted to 17.5"0.3 mM 1.12"0.02 mgrml ,
using an extinction coefficient of 15.0 mMy1rcmy1
w xfor absorbance values at 577 nm 23 .
2.2. Phospholipid ˝esicles
SUVs and LUVs were prepared at 48C from multi-
lamellar lipid vesicles of bovine brain phos-
 .phatidylserine Avanti Polar Lipids; Alabaster, AL
w xin N saturated PEN7.4, as previously described 14 .2
We believe that no hydroxyl free radicals or hydro-
gen peroxide were generated during SUV preparation
w x  .14 . Absorbance values at 230 nm A and 215230
 .nm A of lipid samples were obtained and their215
 .ratios A rA were taken to represent conju-230 215
w xgated diene contents 14 . If the values were higher
than 0.3, the lipid samples were discarded.
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2.3. Incubation of Hb with lipid ˝esicles
 .Purified Hb COHb or oxyHb with final Hb con-
 .centrations of 0.22"0.02 mgrml 3.4"0.3 mM
 .was introduced to pre-warmed 378C for about 5 min
 .lipid vesicles 2.2 mgrml with a lipid to hemoglobin
w xmolar ratio of ;890 14 . The samples were allowed
to incubate at 378C for up to 20 h on a nutator.
For samples under CO conditions, the system was
kept saturated with CO and sealed from the atmo-
sphere to avoid conversion of COHb to oxyHb.
2.4. Vesicle size determination
Photon correlation spectroscopy of QELS mea-
surements with a particle size analyzer BI 90,
.Brookhaven Instruments, New Haven, CT was used
to determine the hydrodynamic effective diameters of
vesicles incubated with different Hb samples, using
w xprocedures published earlier 25 . At least two differ-
ent lipid concentrations were used for each sample to
show that the diffusion coefficient of the sample did
not change upon dilution. Cumulant analysis was
applied to light scattering data to give effective diam-
w xeters and polydispersity 25 .
Turbidity measurements absorbance at 700 nm,
.A were obtained with a DU65 Beckman spectro-700
photometer. These A values of Hb-vesicle sam-700
ples, using buffer as blank, were measured as a
function of time. For samples containing vesicles and
Hb, the maximum absorbance of fully oxidized Hb at
700 nm was 0.01, due to choleglobin formation, at
w xthe Hb concentration used for this study 14 . There-
fore, A values above 0.01 was attributed to light700
scattering from vesicles.
TEM was performed on the sonicated and extruded
vesicles using both freeze fracture and negative stain
techniques. Freeze fracture TEM was carried out by
 .Northern Lipids Vancouver, BC, Canada using
standard procedures. All samples were incubated for
10 h at 378C before being packed and stored on ice
for transporting to Northern Lipids. Negative stain
TEM was performed using a standard 5% uranyl
acetate stain and formvar coated grids. To insure
reasonable quality TEM data, the lipid and Hb con-
centrations in these experiments were about 10-fold
higher than those used in QELS and A measure-700
ments. However, the lipid to Hb molar ratios were
the same in all studies.
3. Results
3.1. Vesicle size
Micrographs of freeze fracture TEM of LUVs 25
.mgrml in PEN7.4 revealed that the vesicles were
indeed spherical with initial diameters of about 100
 .nm Fig. 1A . The vesicles remained spherical after
 .incubation with either oxyHbA 2.5 mgrml or oxy-
HbS at 378C for 10 h, but with the diameters of the
vesicles increased to ;200 nm for vesicles incu-
 .bated with oxyHbA Fig. 1B and ;400 nm for
 .vesicles incubated with oxyHbS Fig. 1C . The val-
ues for systems with vesicles incubated with and
without oxyHbA were similar to those reported ear-
w xlier under similar experimental conditions 14 . No
HbA or HbS aggregates were observed on the lipid
vesicle surface, as compared with Hb precipitation
w xseen by EM under different conditions 26 . Negative
 .stain TEM measurements data not shown did not
indicate any precipitated or aggregated particles of
Hb on vesicles.
QELS data were obtained on both LUV and SUV
 .samples 2.2 mgrml with and without oxyHbA or
 .oxyHbS 0.22"0.02 mgrml incubated at 378C. The
effective diameters and polydispersity values of the
 .vesicles were determined Table 1 . In the absence of
Hb, after incubation in buffer at 378C for about 10 h,
the effective diameters were ;110 nm for LUVs,
and were ;70 nm for SUVs. These values were
w xsimilar to those of fresh vesicle samples 14 , indicat-
ing that vesicles underwent little size changes in the
absence of Hb. Under similar conditions, but in the
presence of oxyHb, effective diameters increased to
;290 nm for LUVs containing oxyHbA, and ;400
nm for LUVs containing oxyHbS. The effective di-
ameters for SUVs were ;220 nm for samples con-
taining oxyHbA and ;300 nm for samples contain-
ing oxyHbS. The polydispersity values for all mea-
surements ranged from 0.048 to 0.214. Polydispersity
values provided information on the relative width of
the diameter distribution. Samples with values below
0.080 were considered to have narrowly distributed
w xdiameters 25 . The polydispersity for LUV samples
was about 0.048, indicating that the LUV effective
diameters were narrowly distributed around 110 nm,
as expected. For the SUV system, the polydispersity
 .value 0.214 was larger, also as expected, since
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 .Fig. 1. The freeze fracture electron micrographs of A BPS
 .  .  .LUVs 20 mgrml and B BPS LUVsqoxyHbA 0.21 mgrml ,
 .and C LUVsqoxyHbS, incubated in PEN7.4 for 10 h at 378C.
 .The scale bar at bottom of C is 200 nm. The diameters of LUVs
 .  .  .are about 100 nm in A , 200 nm in B and 400 nm in C .
SUVs were only metastable with a large size distribu-
tion. We believe that these effective diameter values
obtained from cumulant analysis of QELS measure-
ments were fairly reliable, since the analysis assumed
particles to be spheres, and the majority of the vesi-
cles appeared spherical in TEM micrographs. It was
interesting to note that the effective diameter values
determined by QELS ;110 nm for LUVs and ;70
.nm for SUVs were generally greater than the diame-
ter values determined by TEM ;100 nm for LUVs
. w xand ;30 nm for SUVs 27 .
 .To determine whether precipitated denatured Hb
affected the analysis of QELS measurements, we
added precipitated HbS, from mechanical agitation of
COHbS at 0.2 mgrml, to LUV samples. We ob-
served only an increase in the ‘dust factor’ in the
QELS measurements, but not in the effective diame-
ters of LUVs. They remained at ;110–120 nm.
Thus the increase in sizes as observed by TEM and in
effective diameter measurements in vesicles incu-
bated with oxyHb was due to vesicle fusion. Vesicles
fusion by amphiphilic peptides has been observed to
w xproduce large vesicles 20 . Furthermore, vesicle fu-
sion by apohemoglobin has been observed at low pH
 . w xpH 4 6 .
We also used vesicle turbidity absorbance at 700
.  .nm to follow vesicle fusion. If the mean radius R
of the diffusion particles remains less than the wave-
 . length, then turbidity t is proportional to R ts
8pr3= i R2rI , where i is light scattered at zero0 0 0
w x.angle, and I is the incident light, Ref. 28 and can0
be used as a sensitive measure of particle size distri-
bution. Thus, the A values were converted to700
values we defined as ‘scattering diameters’ with a
calibration curve derived from QELS effective diam-
eter values. We first demonstrated that the A700
values of samples with a particular vesicle size exhib-
ited linear concentration dependence. For both LUVs
and SUVs, A increased linearly upon increase in700
 .lipid concentrations Fig. 2 , with a slope of 0.0295
 2 .for LUVs correlation coefficient, r s0.997 , and a
 2 .slope of 0.0069 for SUVs r s0.984 . For LUV and
SUV samples at concentrations other than 1 mgrml,
these linear relationships were applied to give nor-
malized A readings of vesicles at 1 mgrml lipid700
 .concentrations, A 1 mgrml . A values of vari-700 700
ous LUV and SUV samples with and without oxyHb
incubated for different time periods and correspond-
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Table 1
The various types of diameter from different methods for BPS SUVs and LUVs alone, or with either OxyHbA or OxyHbS, incubated in
PEN7.4 at 378C for 10 h
a .  .  .  .Sample Effective diameter nm QELS Diameter nm TEM Scattering diameter nm A 1 mgrml700
b .LUVs 111 0.048 100 150
c  .LUVsqoxyHbA 290 0.191 200 260
 .LUVsqoxyHbS 405 0.145 400 340
d .SUVs 73 0.214 30 40
 .SUVsqoxyHbA 222 0.189 y 160
 .SUVsqoxyHbS 296 0.210 y 250
aValues obtained from light scattering measurements at 700 nm. See text for definition.
bValues in parenthesis are the polydispersity values for the effective diameter obtained from QELS measurements.
cLipid concentrations were about 2.2 mgrml and LipidrHb molar ratios were about 890.
d w xValue obtained from literature 27 .
ing QELS effective diameter values were measured
simultaneously on the same samples. A values700
 .were then normalized to A 1 mgrml values. We700
 .found that A 1 mgrml and QELS effective700
diameter values correlated well.
Regression analysis of these data points revealed a
 2 .linear dependence r s0.970 with a slope of 2.4=
y4  .10 Fig. 3 . Scattering diameter values were then
 .obtained from A 1 mgrml values using the700
 .following equation: scattering diameter nm sA700
 .  .Fig. 2. The absorbance at 700 nm of SUVs v and LUVs B
at different lipid concentration in PEN7.4 buffer at 378C. The
linear relationship was used to normalize the absorbance readings
of vesicles at concentrations other than 1 mgrml. The following
regression analysis results were obtained. For SUVs, A 1700
.  .  2 .mgrml s0.0069=conc. mgrml r s0.984 , and for LUVs,
 .  .  2 .A 1 mgrml s0.0295=conc. mgrml r s0.997 .700
 . y41 mgrml r2.4=10 . This approach provided us a
convenient means to follow the ‘size’ of vesicles as a
function of time in a consistent manner under differ-
ent experimental conditions in mixtures of vesicles
and Hb molecules. It was interesting to note that the
scattering diameter for LUV was ;150 nm and for
SUV was ;40 nm. These values were similar, but
not identical, to the corresponding values obtained by
 .QELS and TEM measurements Table 1 with their
differences ranging from 10 to 50% of each other.
 .Fig. 3. The correlation between A 1 mgrml and effective700
diameter values determined by QELS measurements. SUVs and
LUVs in PEN7.4 with and without various amounts of Hb were
used for simultaneous measurements of A and QELS effective700
diameter. The two types of measurements correlated rather well
 2 .  y4.r s0.970 . The slope 2.4=10 was used to convert A700
 .1 mgrml values to what we defined as scattering diameters
 .nm .
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3.2. Effects of oxyHbA and oxyHbS on ˝esicle size
increase
In monitoring Hb induced vesicle fusion kinetics,
we followed A values as a function of time and700
determined the rates of scattering diameter increase
for either LUVs or SUVs in the presence of oxyHb.
A clear difference in the rate of fusion between
oxyHbA-vesicle and oxyHbS-vesicle systems was
observed in paired runs. As shown in Fig. 4A, LUVs
exhibited a rapid initial increase in scattering diame-
ters upon incubation with oxyHb, followed by a
slower increase, and appeared to level off eventually
 .Fig. 4. A Mean scattering diameters for 6 runs of BPS LUVs in
 .  .the presence of oxyHbA I and oxyHbS B at 378C as a
function of time. The lines in the insets were linear regression
 .lines on data of the first 3 h. The slope rate for oxyHbA-LUV
 .  2 .dotted line was 7.8 nmrh r s0.996 and for oxyHbS-LUV
 2 .  .  .was 16.4 nmrh r s0.987 solid line B Mean scattering
diameters for 6 runs of BPS SUVs in the presence of oxyHbA
 .  .‘ and oxyHbS v . The lines in the insets were linear
 .regression lines on data for the first 3 h. The slope rate for
 .  2 .oxyHbA-SUV dotted line was 17.3 nmrh r s0.983 , and for
 .  2 .oxyHbS-SUV solid line was 33.4 nmrh r s0.997 .
 .after 15–20 h to ;380 nm for oxyHbS and to
 .;300 nm for oxyHbA. The initial first 3 h fusion
rates were obtained from the slopes of the linear
regression lines of the data obtained during the first 3
 2 .h, and was 7.8 nmrh for oxyHbA-LUV r s0.983
 2 . and 16.4 nmrh for oxyHbS-LUV r s0.994 Fig.
.4A inset . OxyHbS appeared to destabilize lipids in
LUVs at a rate 2.1 times faster than oxyHbA.
Since Hb tetramers dissociate to dimers at low
w xconcentrations, with a K of about 2 mM 29 , and,d
if HbA and HbS were to exhibit different dissociation
properties, the presence of various amounts of dimers
could complicate our interpretation of the data. How-
ever, in our previous studies of Hb oxidation in the
presence of vesicles, we did not observe increased
oxidation upon decreasing Hb concentration in the
w xconcentration range of 3–100 mM 14 , indicating
that lipid-enhanced oxidation was not much affected
by tetramer dissociation. In this study, the observed
fusions in our TEM samples, which were at about 40
mM, were similar to those observed in A and700
QELS samples, which were at about 3.5 mM. Under
these two concentration conditions, the tetramer to
 .dimer ratios were quite different about 4-fold and
yet we observed similar effects. In addition, recent
w xmeasurements of K of HbS 30 suggested valuesd
similar to those of HbA. Therefore the effects that we
observed could not be attributed to specific properties
of dimers or tetramers.
As shown in Fig. 4B, the Hb induced fusion for
SUVs occurred at even faster rates. Scattering diame-
ters increased rapidly, from ;40 nm at ts0, during
the first 5 h before levelling off to about 270 nm for
oxyHbS and to about 200 nm for oxyHbA at the end
of 18-h incubation at 378C. The scattering diameter
values for the first 3 h were analyzed by linear
regression, and found to have an initial fusion rate of
 2 .17.3 nmrh for oxyHbA-SUV r s0.991 and 33.3
 2 .  .nmrh for oxyHbS-SUV r s0.998 Fig. 4B inset .
Again, oxyHbS appeared to destabilize lipids in SUV
at a faster rate, 1.9 times faster, than oxyHbA.
3.3. Effects of COHbA and COHbS on ˝esicle size
increase
The oxidation of oxyHb was enhanced in the
w xpresence of LUVs or SUVs 14 . OxyHb, in SUV
systems with lipid to Hb molar ratios of 800, was
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converted completely to oxidation products metHb,
.hemichrome, choleglobin, etc. in about 1 h. Under
the same conditions, but in the presence of LUVs,
oxyHb converted completely to oxidation products in
about 10 h. Thus, the complex behavior observed in
the kinetics of vesicle fusion in oxyHb-vesicle sys-
tems was anticipated. To avoid oxidation complica-
tions, we studied the effects of COHb, in the absence
of any metHb, on vesicle fusion. As indicated in
Section 2, special care was needed to ensure the
integrity of COHb throughout the incubation periods.
Upon incubation with COHb, up to 20 h, scattering
diameters for both LUVs and SUVs followed a rather
 .simple, linear increase as a function of time Fig. 5 .
The rates were 2.9 nmrh for COHbA-LUV system
 .Fig. 5. A Mean scattering diameters for 6 runs of BPS LUVs in
 .  .the presence of COHbA I and COHbS B at 378C as a
function of time. The lines were linear regressions for all data.
 .  .The slope rate for COHbA-LUV dotted line was 2.9 nmrh
 2 .  .r s0.981 and for COHbS-LUV solid line was 4.9 nmrh
 2 .  .r s0.931 . B Mean scattering diameters for six runs of BPS
 .  .SUVs in the presence of COHbA ‘ and COHbS v . The
 .lines were linear regressions for all data. The slope rate for
 .  2 .COHbA-SUV dotted line was 7.6 nmrh r s0.978 and for
 .  2 .COHbS-SUV solid line was of 12.3 nmrh r s0.962 .
Table 2
The rates of scattering diameter increase of vesicles in the
presence of OxyHb or COHb in PEN7.4 at 378C
 .  .System Rate nmrh Rate ratio HbSrHbA
HbA HbS
aLUVsqOxyHb 7.8 16.4 2.1
SUVsqOxyHb 17.3 33.4 1.9
bLUVsqCOHb 2.9 4.9 1.7
SUVsqCOHb 7.6 12.3 1.6
aFirst 3 h data were used for systems containing OxyHb. During
this time period, the increase was linear. See Fig. 4. The concen-
trations of lipid were about 2.2 mgrml and LipidrHb molar
ratios were about 890.
bFirst 25 h data were used for systems containing COHb. During
this time period, the increase was linear. See Fig. 5.
 .and 4.9 nmrh for COHbS-LUV system Fig. 5A .
The increase in LUV scattering diameters was rela-
tively slow for COHb. However, COHbS produced a
rate 1.7 times faster than COHbA. A Student’s t-test
on these data indicated that the difference between
COHbS and COHbA systems was statistically signifi-
cant with a P value of 0.08.
For the SUV system, the rate was 7.6 nmrh for
 .COHbA and 12.3 nmrh for COHbS Fig. 5B . Again,
COHbS increased vesicle fusion at a rate 1.6 times
faster than COHbA. A Student’s t-test on these data
indicated that the difference between COHbS and
COHbA systems was statistically significant with a P
value of 0.02.
All the rates for COHb-vesicle systems were
smaller than the corresponding ones for oxyHb-vesicle
systems, further supporting the suggestion that fu-
sions observed in oxyHb-vesicle systems were, in
part, due to oxidation products.
A summary of the fusion rates of both COHb and
oxyHb is given in Table 2.
4. Discussion
Studies on hemichrome or Heinz bodies formation
have been focused on membrane proteins and found
that, for example, Hb oxidation products destabilize
w xspectrin association 31 , and hemichrome copolymer-
w xizes with Band 3 to give Heinz bodies 32 . Involve-
ments of lipid surface toward Hb-membrane interac-
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tion were not clear. We showed that, under physio-
logical pH and ionic strength conditions, lipid vesi-
cles, either LUVs or SUVs, were relatively stable
with constant sizes for at least 20 h at 378C. How-
ever, the introduction of oxyHb molecules, with less
than 1% oxidized Hb, to vesicles caused the vesicles
to increase in size, suggesting that oxyHb destabi-
lized the lipid vesicles leading to vesicle fusion.
Fusogenic properties of myoglobin have been
demonstrated at pH 4 and were attributed to partial
unfolding of m yoglobin helices at the
w xmembranerwater interface at acidic pH 33 . Further,
 .human apohemoglobin in acidic media pH 4 was
w xfound to induce fusion of PCrPS vesicles 6 . Our
data showed that Hb was also fusogenic at pH 7.4 in
PEN7.4 buffer. The association of water-soluble pro-
teins with liposomes is thought to be either primarily
dependent on the overall electrostatic, Coulombic
attraction between the membrane- and protein-associ-
w xated charges 33–35 , or mainly dependent on hy-
drophobic interactions, with only a minor contribu-
tion from the charge characteristics of the proteins
w x36–40 . Subsequent to protein-liposome association,
some proteins induce vesicle fusion either by insert-
ing their hydrophobic a-helical regions into mem-
w xbrane bilayers 41,42 or by adopting an a-helical
conformation with their axis parallel to the membrane
w xsurface 20 . The last step involves pore formation
and vesicle fusion. These studies imply that direct
contact of proteins with vesicles induces fusion. In
addition, it has also been demonstrated that, if a
protein does not interact with liposome membranes, it
w xdoes not exhibit membrane fusion activities 33,43 .
Thus, by showing fusogenic properties of Hb, we
show that Hb interacts with lipid membranes at
physiological pH and ionic strength conditions.
 .The kinetics rates of vesicle fusion may be used
as a quantitative measure of protein–lipid interac-
tions. We used values of optical absorbance at 700
nm to determine the rates of vesicle scattering diame-
ter increase under different conditions. We found
that, for the first 3 h, the fusion rate for LUVs in the
oxyHbA-vesicle system was 7.8 nmrh. However,
oxidation products were detected upon incubation of
w xoxyHb with lipid vesicle systems 14 . Thus, in the
oxyHb-LUV system, fusogenic properties may not be
attributed simply to oxyHb molecules. Oxidation
products of both Hb and lipid may exert different
effects toward vesicle fusion. Lipid peroxidation
products, such as lipid hydroperoxides of the fatty
acid components of phospholipids, cyclic peroxides
and epoxides have all been shown to promote vesicle
w xfusion 44 . However, in the COHbA-LUV system,
no Hb oxidation or lipid peroxidation was detected,
and fusion in LUVs, under conditions that showed
little fusion in the absence of Hb, could only be
attributed to Hb molecules. We observed a simple
fusion kinetics for COHbA-LUV system with a fu-
sion rate of 2.9 nmrh, a rate slower than that found
in oxyHb-LUV system, as expected.
Similar kinetics were observed for SUV-Hb sys-
tems indicating that Hb did not exhibit only specific
interactions with LUV surface, rather that Hb inter-
acted with lipid surfaces in general. Rates of Hb
mediated fusion in SUV systems were much faster
than those in LUV systems, probably due to the
meta-stable nature of SUVs. In an earlier study,
SUVs were shown to fuse more readily than LUVs
2q w xwhen incubated with Mg 17 .
It has been proposed that proteins with higher
w xhydrophobicity may be more fusogenic 16,20,43 . In
addition, an N-terminal segment of the b subunit of
Hb with a molecular mass of approximately 6 kDa
was found to be responsible for the fusogenic proper-
w xties of Hb at pH 4 6 . Thus, HbS, with b6Glu being
replaced by Val, an amino acid with a hydrophobic
side chain, would be expected to exhibit higher fu-
sion rate than HbA, even under physiological pH and
ionic strength conditions. And our results demon-
strated this to be the case. The fusion rate for LUVs
with COHbS in PEN7.4 buffer at 378C was 4.9
nmrh, a rate about 1.7-fold higher than that of
COHbA. For SUVs with COHb, the fusion rate was
7.6 nmrh for HbA and 12.3 nmrh for HbS. Thus,
the fusion rates for both types of vesicles were about
1.6–1.7 times faster for COHbS than for COHbA.
HbS molecule, with higher hydrophobicity, interacts
more extensively with lipid surfaces than HbA
molecule.
 .In addition to the local b6 amino acid hy-
drophobicity difference between HbA and HbS, NMR
studies of the aromatic regions of COHbA and CO-
HbS show that some of the surface histidine residues
w xhave different conformations in HbA and HbS 45 .
Different proton binding properties were demon-
strated between COHbA and COHbS, and it was
( )C.C. LaBrake, L.W.-M. FungrBiochimica et Biophysica Acta 1406 1998 152–161160
suggested that the difference was due to conforma-
tional changes in the A helix in COHbS to give pK
w x w xshift in b 2His 46 . Elbaum et al. 47 have found
that there are differences in the surface properties
between HbA and HbS. These surface conformational
differences may also contribute towards the enhanced
fusogenic effects for HbS over HbA.
Our finding that HbS exhibited a stronger affinity
for the lipid surface than HbA under physiological
pH and ionic strength conditions at 378C may provide
insights toward understanding sickle cell abnormali-
ties. In red cells from patients with sickle cell ane-
w xmia, HbS denatures to form Heinz bodies 1 . Mem-
brane-associated HbS has been suggested to be a
major determinant of sickle erythrocyte rigidity
w x48,49 . It has been suggested that abnormal HbS
oxidation is responsible for excess hemichrome for-
w xmation in sickle cells 5 . However, abnormal HbS
oxidation was observed at low pH and ionic strength
w xconditions 5 . Our earlier work, using protein spin
label electron paramagnetic resonance methods, has
shown that COHbS exhibits a higher affinity toward
erythrocyte membranes than COHbA under physio-
w xlogical pH conditions 24 . The dissociation constant
 . y5K was 1.3=10 M for COHbS-membrane sam-d
ples, and 2.8=10y5 M for COHbA-membrane sam-
ples at pH 7.4. The ratio of these K values was 2.2.d
In addition, HbS precipitates upon mechanical agita-
w xtion at physiological pH and ionic strength 50 .
Surface isotherms show a greater unfolding of the
w xoxyHbS than oxyHbA at an air–water interface 51 .
Yet the physiological relevance of these air–water
activities and mechanical precipitation is not fully
appreciated. Similar precipitation at the lipid–water
interface in cells may be possible. We suggest that, in
the absence or presence of Hb oxidation, the surface
activities of HbS at the lipid–water interface promote
abnormal HbS-membrane interactions. Following
these interactions, lipid surface enhanced Hb oxida-
w xtion 14 occurs, and thereby facilitating the pathol-
ogy of the sickle RBC membrane. Further studies
providing quantitative understanding of Hb–lipid in-
teractions may reveal the interaction mechanisms be-
tween electrostatic and hydrophobic bindings of Hb
 .and lipid molecules. Molecules drugs capable of
decreasing HbS surface hydrophobicity maybe useful
in reducing HbS-cell membrane association.
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